What does Dermatologie Kempenland do?

Dermatologie Kempenland is a specialist medical practice in Beerse. Private Limited, started on 2 July 2013, 2 establishments.

What is the address of Dermatologie Kempenland?

The registered office of Dermatologie Kempenland is located at Kempenlaan 36, 2340 Beerse.

Is Dermatologie Kempenland still active?

Yes. According to the CBE (29 October 2026) Dermatologie Kempenland is active, legal situation “Normale toestand”, started on 2 July 2013.

Is Dermatologie Kempenland registered on Peppol?

Yes, Dermatologie Kempenland is registered on the Peppol network with ID 0208:0536422371.

What is the enterprise number of Dermatologie Kempenland?

The enterprise number of Dermatologie Kempenland is BE0536422371.

When was Dermatologie Kempenland founded?

Dermatologie Kempenland was founded on 2 July 2013.

Is Dermatologie Kempenland a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 July 2013; 5 annual accounts filed, latest fiscal year 2025; 6 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dermatologie Kempenland make in 2025?

Dermatologie Kempenland posted a profit after taxes of € 37,503 in financial year 2025.

What is the revenue of Dermatologie Kempenland?

As a small company, Dermatologie Kempenland is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,037,642.

How much does an employee at Dermatologie Kempenland earn?

The average wage cost per full-time employee at Dermatologie Kempenland was € 73,100 in 2025: staff costs of € 789,977 for 10.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Dermatologie Kempenland have?

According to the 2025 annual accounts, Dermatologie Kempenland has 10.8 full-time equivalents (FTE).

Dermatologie Kempenland (Private Limited) - Beerse

Q: Who are the directors of Dermatologie Kempenland?

According to the 2025 annual accounts, the directors of Dermatologie Kempenland are: HEYLEN DERMATOLOGIE BV, BR DERMATOLOGIE BV, MF DERMATOLOGIE BV, VALIDERM BV, CORTIS1 BV, DR. MAS DERMATOLOGIE BV.

Dossier Dermatologie Kempenland, printed on 29 October 2026 from databakkes.be/en/0536422371/dermatologie-kempenland. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dermatologie Kempenland from Beerse, company number BE0536422371, closed financial year 2025 with a result of € 37,503 after tax. For that financial year Dermatologie Kempenland recorded a gross margin of € 1 million and equity of € 24,000. Compared with financial year 2024, the result moved from € 36,973 to € 37,503. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Healthy

€ 24,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 37,503

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.2 million

▲ 77% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 37,503 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

10.8

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 789,977

▲ 15% vs 2024

€ 73,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 12,008

▼ 8% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 124,393

▲ 4% vs 2024

€ 44,589 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 331,205

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 115,689

▲ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 666,845 Gross margin 2022: € 666,845 First fiscal year in the series	€ 705,587 Gross margin 2023: € 705,587 ▲ 6% vs 2022 (€ 666,845) Favourable step	€ 875,585 Gross margin 2024: € 875,585 ▲ 24% vs 2023 (€ 705,587) Favourable step	€ 1,037,642 Gross margin 2025: € 1,037,642 ▲ 19% vs 2024 (€ 875,585) Favourable step	▲ 19%
Profit after taxes	€ 37,049 Profit after taxes 2022: € 37,049 First fiscal year in the series	€ 36,367 Profit after taxes 2023: € 36,367 ▼ 2% vs 2022 (€ 37,049) Unfavourable step	€ 36,973 Profit after taxes 2024: € 36,973 ▲ 2% vs 2023 (€ 36,367) Favourable step	€ 37,503 Profit after taxes 2025: € 37,503 ▲ 1% vs 2024 (€ 36,973) Favourable step	▲ 1%
Equity	€ 24,000 Equity 2022: € 24,000 First fiscal year in the series	€ 24,000 Equity 2023: € 24,000 Unchanged (€ 24,000) Unchanged	€ 24,000 Equity 2024: € 24,000 Unchanged (€ 24,000) Unchanged	€ 24,000 Equity 2025: € 24,000 Unchanged (€ 24,000) Unchanged
Total debts	€ 728,332 Total debts 2022: € 728,332 First fiscal year in the series	€ 1,012,626 Total debts 2023: € 1,012,626 ▲ 39% vs 2022 (€ 728,332) Unfavourable step	€ 1,215,093 Total debts 2024: € 1,215,093 ▲ 20% vs 2023 (€ 1,012,626) Unfavourable step	€ 1,847,256 Total debts 2025: € 1,847,256 ▲ 52% vs 2024 (€ 1,215,093) Unfavourable step	▲ 52%
Cash	€ 329,197 Cash 2022: € 329,197 First fiscal year in the series	€ 538,770 Cash 2023: € 538,770 ▲ 64% vs 2022 (€ 329,197) Favourable step	€ 658,122 Cash 2024: € 658,122 ▲ 22% vs 2023 (€ 538,770) Favourable step	€ 1,162,196 Cash 2025: € 1,162,196 ▲ 77% vs 2024 (€ 658,122) Favourable step	▲ 77%
Land & buildings	€ 8,554 Land & buildings 2022: € 8,554 First fiscal year in the series	€ 7,643 Land & buildings 2023: € 7,643 ▼ 11% vs 2022 (€ 8,554) Unchanged	€ 28,651 Land & buildings 2024: € 28,651 ▲ 275% vs 2023 (€ 7,643) Unchanged	€ 31,230 Land & buildings 2025: € 31,230 ▲ 9% vs 2024 (€ 28,651) Unchanged	▲ 9%
Dividend	€ 37,049 Dividend 2022: € 37,049 First fiscal year in the series	€ 36,367 Dividend 2023: € 36,367 ▼ 2% vs 2022 (€ 37,049) Unchanged	€ 36,973 Dividend 2024: € 36,973 ▲ 2% vs 2023 (€ 36,367) Unchanged	€ 37,503 Dividend 2025: € 37,503 ▲ 1% vs 2024 (€ 36,973) Unchanged	▲ 1%
Bank debt	€ 120,326 Bank debt 2022: € 120,326 First fiscal year in the series	€ 133,569 Bank debt 2023: € 133,569 ▲ 11% vs 2022 (€ 120,326) Unfavourable step	€ 119,133 Bank debt 2024: € 119,133 ▼ 11% vs 2023 (€ 133,569) Favourable step	€ 124,393 Bank debt 2025: € 124,393 ▲ 4% vs 2024 (€ 119,133) Unfavourable step	▲ 4%
Balance sheet total	€ 752,332 Balance sheet total 2022: € 752,332 First fiscal year in the series	€ 1,036,626 Balance sheet total 2023: € 1,036,626 ▲ 38% vs 2022 (€ 752,332) Unchanged	€ 1,239,093 Balance sheet total 2024: € 1,239,093 ▲ 20% vs 2023 (€ 1,036,626) Unchanged	€ 1,871,256 Balance sheet total 2025: € 1,871,256 ▲ 51% vs 2024 (€ 1,239,093) Unchanged	▲ 51%
Employees (FTE)	7.5 Employees (FTE) 2022: 7.5 First fiscal year in the series	7.6 Employees (FTE) 2023: 7.6 ▲ 0.1 vs 2022 (7.5) Unchanged	10.3 Employees (FTE) 2024: 10.3 ▲ 2.7 vs 2023 (7.6) Unchanged	10.8 Employees (FTE) 2025: 10.8 ▲ 0.5 vs 2024 (10.3) Unchanged	▲ 0.5

Key figures of Dermatologie Kempenland, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dermatologie Kempenland?

What happened at Dermatologie Kempenland in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 37,503 (▲ 1% vs 2024). Source: NBB ↗
2025 VALIDERM BV became a director. NBB
2025 CORTIS1 BV became a director. NBB
2025 BR DERMATOLOGIE BV became a director. NBB
2024 MF DERMATOLOGIE BV became a director. NBB
2023 DR. MAS DERMATOLOGIE BV became a director. NBB
May 17, 2021 New establishment in Turnhout. KBO
2021 HEYLEN DERMATOLOGIE BV became a director. NBB

In short

From € 37,049 profit in 2022 to € 37,503 profit in 2025.

Paid € 52,108 in corporate taxes since 2022.

Best year ever: 2025, with € 37,503 profit.

On average € 96,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DR. MAS DERMATOLOGIE 41.7%

HEYLEN DERMATOLOGIE 33.3%

MF DERMATOLOGIE 25%

The stake of DR. MAS DERMATOLOGIE, HEYLEN DERMATOLOGIE, MF DERMATOLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Dermatologie Kempenland

Behind Dermatologie Kempenland are HEYLEN DERMATOLOGIE BV, BR DERMATOLOGIE BV, MF DERMATOLOGIE BV, VALIDERM BV, CORTIS1 BV and DR. MAS DERMATOLOGIE BV. The shares are held by DR. MAS DERMATOLOGIE (41.7%), HEYLEN DERMATOLOGIE (33.3%) and MF DERMATOLOGIE (25%).